Volpara bid underwhelming but hard to beat: Bell Potter

Volpara bid underwhelming but hard to beat: Bell Potter
Volpara has developed a breast cancer detection system. (Image: NZME)
Pattrick Smellie
The bid by South Korean firm Lunit to take over fast-growing Wellington medical AI provider Volpara Technologies at A$1.15 (NZ$1.124) a share is no more than “good enough”, but is unlikely to be beaten, says Sydney broking house Bell Potter.Pitched at a 47.4% premium to Australian securties exchange-listed (ASX) Volpara’s closing price on Dec 13, the offer values the company, which is on the cusp of profitability after more than seven years as a publicly listed company, at a “mere US$193 million [NZ$311m]”.How...

More Markets

Mercury announces reshuffle at its top table
Finance

Mercury announces reshuffle at its top table

The two new members of the executive team are internal candidates.

Cuncannon: building a plaintiff side law firm
Markets

Cuncannon: building a plaintiff side law firm

The class action industry in New Zealand is somewhat underdeveloped.

Why Ebos is hunting SMEs
Markets

Why Ebos is hunting SMEs

What's next for Ebos after the end of that Chemist Warehouse contract.

Spark outlines more possible asset sales
Finance

Spark outlines more possible asset sales

The Spark board has a calculation to make about dividend reinvestment policy.